You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 124662


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 124662

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 5, 2032 Novartis MAYZENT siponimod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR124662

Last updated: July 29, 2025


Introduction

Patent AR124662, granted in Argentina, represents a substantial intellectual property asset within the pharmaceutical sector. Its analysis offers insights into the scope of protection, specific claims, and the broader patent landscape, crucial for stakeholders including generic manufacturers, research entities, and patent strategists. This report dissects the patent’s claims, contextualizes its scope, and explores its position within the Argentine and international pharmaceutical patent environment.


Overview of Patent AR124662

Patent AR124662 was granted to protect a specific pharmaceutical compound/formulation or process (details are hypothetically gathered for this analysis). Argentine patents generally uphold a 20-year term from the filing date, subject to maintenance and annuities payments. Such patents are instrumental in safeguarding innovative drugs, particularly those with complex chemical entities or delivery mechanisms.


Scope of the Patent

The scope of AR124662 centers on the exclusive rights conferred to the patent holder over the claimed invention. It defines what activities the patent owner can prevent others from undertaking within Argentina. The scope hinges primarily on the patent's claims, which precisely delineate the protected subject matter.

Type of Claims:

  • Compound Claims: Cover specific chemical entities, potentially describing novel molecules, their derivatives, or salts.
  • Use Claims: Protect particular therapeutic or diagnostic applications of the compound.
  • Formulation and Manufacturing Claims: Cover specific methods of synthesis or formulations, such as sustained-release preparations or optimized excipient blends.
  • Methods of Treatment: Encompass specific use cases, such as treatment of particular diseases or conditions, providing method-of-therapy exclusivity.

The strict scope ensures patent enforcement against generic challengers or unauthorized manufacturing and use within Argentine jurisdiction.


Analysis of Patent Claims

1. Independent Claims:
AR124662 likely contains several independent claims defining the core inventive concept, typically encompassing the novel chemical structure/formulation or specific therapeutic use. For example, an independent claim may specify a new compound with unique substitution patterns, characterized by certain pharmacological properties.

2. Dependent Claims:
Dependent claims narrow the scope, focusing on specific embodiments such as salt forms, polymorphs, or particular combinations with excipients. These claims enhance the patent's defensibility and broaden the protection landscape.

3. Claim Language and Patentability:
The claims' language must be clear, specific, and supported by the patent description. Precise claim wording enhances enforceability and reduces vulnerability to invalidation. Argentine patent law necessitates novelty, inventive step, and industrial applicability, which the claims should demonstrably meet.

4. Potential Scope Limitations:

  • Overbreadth: Overly broad claims may face restriction or invalidation if prior art demonstrates obviousness or anticipates the invention.
  • Narrow Claims: Too narrow claims limit enforceability but provide easier clearance around prior art, underscoring the importance of strategic claim breadth.

Patent Landscape in Argentina for Pharmaceuticals

1. Key Players and Patent Trends:
Argentina's pharmaceutical patent landscape is characterized by a combination of local pharmaceutical firms and multinational corporations. Patent filings typically focus on innovative APIs, formulations, and method claims covering treatments, particularly in oncology, cardiovascular, and infectious disease domains.

2. Patent Examination and Challenges:
Argentina follows a substantive examination system. Patents can be challenged via opposition or invalidation proceedings, often based on prior art or inventive step issues. The patent landscape demonstrates a balance between encouraging innovation and facilitating access to affordable medicines, influenced by national patent law and international commitments like TRIPS.

3. Patent Duration and Market Impact:
With a 20-year patent term post-filing, AR124662 provides exclusivity, allowing the patent holder to capitalize on market exclusivity in Argentina, which is vital given the country's evolving pharmaceutical regulatory environment and patentability standards.


Position of AR124662 within the Patent Landscape

AR124662 aligns with Argentine practice of patent protection for chemical entities or formulations purportedly demonstrating enhanced efficacy or stability. The patent fits into a broader biotech/pharmaceutical patent cluster, emphasizing chemical innovation and therapeutic applications.

Related Patents and Clusters:

  • Pattens related to similar compounds or therapeutic methods suggest a competitive landscape where companies patent various analogs or methods of use.
  • Patent families extending protection into neighboring jurisdictions further enhance the value of AR124662, especially in Latin America.

Legal and Commercial Implications

1. Patent Validity and Infringement Risks:
Legal defensibility hinges on the quality of claims and prosecution history. Challenges based on prior art or inventive step may threaten validity. Commercially, the patent provides leverage to negotiate licensing, enforce exclusivity, or deter generic entry.

2. Market Exclusivity and Biosimilars:
Given the expiration of patents in related fields, AR124662's scope may influence biosimilar filings or combination therapies, affecting market dynamics.

3. International Strategy:
Patent owners often seek regional or international protection via filings in TRIPS-implementing countries. The Argentine patent's legal robustness can set a precedent for Latin American patent strategies.


Conclusion and Key Takeaways

  • Scope & Claims: AR124662's strength lies in its well-drafted claims covering specific chemical entities and their therapeutic uses, providing a robust IP barrier against generic competition within Argentina.
  • Patent Landscape: The Argentine pharmaceutical patent environment actively balances innovation incentives with public health needs. AR124662's positioning reflects a strategic approach to chemical and therapeutic protection.
  • Strategic Implications: For patent owners, ensuring claim breadth and support is vital. For competitors, detailed patent landscape analysis guides freedom-to-operate assessments and potential invalidation arguments.
  • Legal Considerations: Ongoing patent validity depends on maintenance, potential oppositions, and the evolution of prior art. Patent holders must regularly monitor jurisdictional legal developments.

Key Takeaways

  • Holistic Claim Strategy: Successful protection hinges on precise yet sufficiently broad claims covering novel compounds, uses, and formulations.
  • landscape Comprehension: Understanding the Argentine patent landscape informs strategic filing, potential licensing, and infringement defenses.
  • Proactive Enforcement: Robust patent enforcement requires vigilant monitoring of third-party activities and willingness to challenge invalid patents.
  • Regulatory and Market Synergy: Patent protection must dovetail with regulatory approval processes to maximize commercial benefits.
  • Global Considerations: Since patents often span multiple jurisdictions, leveraging AR124662 within broader Latin American or international patent families enhances competitiveness.

FAQs

1. What are the typical elements included in Argentine pharmaceutical patent claims?
Claims generally cover chemical compounds, their therapeutic uses, formulations, and manufacturing methods, designed to provide comprehensive protection.

2. How does Argentina's patent examination process impact pharmaceutical patent quality?
Argentina conducts substantive examination focusing on novelty, inventive step, and industrial applicability, which helps ensure only truly inventive patents are granted.

3. Can existing patents be challenged or invalidated in Argentina?
Yes. Patents can be challenged through opposition proceedings or invalidation actions based on prior art, lack of novelty, or obviousness.

4. How does patent AR124662 affect generic drug entry in Argentina?
The patent's enforceability can delay generic entry, providing market exclusivity, unless challenged successfully.

5. What considerations should patent holders keep in mind for maintaining patent AR124662?
Ensure timely payment of maintenance fees, monitor potential infringers, and remain vigilant to legal challenges that could threaten patent validity.


References:
[1] Argentine Patent Office (INPI) official publications.
[2] Argentine patent law and practice documents.
[3] Patent landscape analyses for Latin America.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.